Tenmile

Revagenix is a precision-therapeutics company that develops drugs for serious chronic diseases, starting from the underlying biology and unmet clinical needs.

BiotechDeep TechHealthtechMedical Devices

Ryan Cirz(Co-founder & CEO)Andrew McCandlish(Co-founder & COO)Peter Smith(Chief Scientific Officer)Daniel Cloutier(VP, Development)

Co-investorsNovo Holdings

AdvanCell is a clinical-stage radiopharmaceutical company developing a pipeline of targeted alpha therapies for the treatment of cancers including prostate, melanoma, ovarian, breast, and lung.

BiotechHealthtechMedical DevicesCambridge, US

Andrew Adamovich(Director)Philina Lee(Executive Officer, Director)Aaron Pickett(Executive Officer)

BoardWing Cheong Lam(Director)Nik Economopoulos(Director)Anthony Aiudi(Director)

Co-investorsBain Capital Life SciencesCatalio Capital Management, LPProto AxiomSV Health InvestorsAbingworthAlly Bridge Group+2 more

Amaroq Therapeutics develops first-in-class therapies targeting long non-coding RNAs (lncRNAs) implicated in oncology and other diseases.

Biotech

Co-investorsBooster Innovation FundCure Kids Ventures

Antares Therapeutics discovers and develops precision medicines, with a focus on small molecule therapies targeting previously undruggable oncology targets and other serious diseases.

AI & Machine LearningBiotechMedical DevicesCambridge, US

Adam Friedman(Chief Executive Officer)inAndrew Fedder(Executive Officer, Director)inBrian Piper(Executive Officer, Director)

Co-investorsAtlas VentureLightspeed Venture PartnersVida VenturesOmega FundsAbingworthBiotechnology Value Fund

AusBiotech is a membership and advocacy organization representing Australia's life sciences ecosystem, including early-stage discovery, development, commercialization, and manufacturing organizations.

BiotechMedical DevicesBrisbane, AU

Carina Biotech develops cell and gene therapy treatments, with ongoing Phase 1/2a clinical trials and research in CAR-TCR technology.

Biotech

Creyon develops cell-specific therapeutics using aptamer-delivered oligonucleotides and other payloads (lipid nanoparticles, nucleic acids) for immune-driven diseases, CNS conditions, and genetic disorders.

AI & Machine LearningBiotech

Co-investorsLux Capital

Creyon develops cell-specific therapeutics using aptamer-delivered oligonucleotides, engineering aptamers to deliver therapeutic payloads to immune cells and across the blood-brain barrier for immune-driven and CNS diseases, plus a splice-switching oligonucleotide program for late-onset Pompe disease.

AI & Machine LearningBiotechDeep Tech

Co-investorsBioBritDCVC (Data Collective)DCVC Bio

Commercial manufacturer of bilateral weight-bearing tomography scanners for orthopaedics.

BiotechMelbourne

Gregory Brown(Director)Ura Phillip Stephen Auckland(Company Secretary)David Seeman(Director)Waradana Malitha Hashan De Silva(Director)Robert Lilley(Director)

CurveBeam AI develops cone beam CT point-of-care medical imaging systems and deep learning software for bone and joint analysis, aiding orthopedic surgeons with 3D deformity measurements and bone microstructure analysis.

AI & Machine LearningHealthtechMedical Devices

Clinical services company collecting patient data and developing novel drug and care models, including MDMA-assisted treatment for PTSD.

Luma provides a platform for creating event pages, sending invitations, and selling tickets for events.

SaaS

Victor Pontis(Founder)in

Co-investorsAllen Institute for AI (AI2) IncubatorAmplify PartnersBerkley Center for EntrepreneurshipBethnal Green VenturesCedar CapitalEIT Urban Mobility Accelerator+13 more

Humanitix is an event ticketing platform that donates 100% of profits to charity.

Impact & Social GoodMarketplacesPhiladelphia, US

Inventia Life Science provides advanced 3D cell culture platforms and reproducible 3D cell models for drug discovery, cancer research, and toxicology assessment.

AI & Machine LearningBiotechMedical Devices

Co-investorsMain Sequence VenturesVU Venture Partners

Kantoko is an Australian telehealth platform offering online ADHD assessment, diagnosis, and ongoing care for adults, delivered by AHPRA-registered ADHD doctors.

Digital HealthHealthtechMental Health

LimmaTech Biologics develops vaccines targeting antimicrobial-resistant pathogens using a proprietary self-adjuvanting, multi-antigen vaccine platform along with disease-specific approaches.

BiotechHealthtech

Co-investorsAdjuvant CapitalAndera Partners

Lumos Diagnostics develops rapid, cost-effective point-of-care diagnostic tests and digital reader platforms for healthcare professionals to assess and manage medical conditions.

BiotechHealthtechMedical Devices

Doug Ward(CEO)Paul Kase(Chief Commercial Officer)

Mindset Health develops digital health programs using hypnotherapy and mind-body medicine to help patients manage gastrointestinal disorders and improve health outcomes.

Digital HealthHealthtechMedical DevicesMental HealthWellness & FitnessMelbourne, AU

Alex Naoumidis(Co-founder & Co-CEO)inChris Naoumidis(Founder)in

Co-investorsAlberts Impact VenturesFifty YearsKing River CapitalPerennial PartnersY CombinatorBanana Capital+1 more

Oncko develops machine learning and experimental platforms to discover optimized multi-drug cancer treatment combinations by screening against resistance mechanisms.

AI & Machine LearningBiotechDeep Tech

Atray Dixit(Co-founder, CEO)inBill Grossman(Co-founder, Strategic Advisor)in

Co-investorsAdverb VenturesIllumina Ventures

Perx provides a digital care management platform for medically complex and high-risk members to improve treatment adherence and health outcomes.

Digital HealthHealthtechSaaS

Co-investorsAirTree VenturesTractor VenturesWildwood Ventures

SpeeDx provides multiplexing technology platforms and diagnostic assays for detecting infectious disease pathogens, including customized solutions for respiratory infections, sexually transmitted infections, gastrointestinal illness, and antimicrobial resistance markers.

BiotechMedical Devices

Proton Intelligence develops CKM™, a continuous monitoring medical device drawing on biosensing and minimally invasive microdevice technology for clinical use.

Deep TechDigital HealthHealthtechMedical Devices

Co-investors15th RockAIN VenturesLongeVC

Developing next-generation cell surface degraders to target previously undruggable proteins in autoimmune conditions and cancers.

Sydney, Nsw

Joshua Ismin(Executive Officer, Director)Samuel Banister(Director)

Developing a drug to remyelinate neurons in multiple sclerosis patients.

Co-investorsBooster Innovation FundMatū

Halle Tecco(Founder)Bill Evans(Founder)in

Co-investorsFlare Capital PartnersKaiser Permanente VenturesNew Enterprise Associates (NEA)Rock Health CapitalSteelSky VenturesStorm Ventures

SpeeDx develops multiplexed molecular diagnostic tests and research assays using its proprietary multiplexing technologies, covering areas such as sexually transmitted infections, respiratory pathogens, and enteric illness along with antimicrobial resistance markers.

BiotechHealthtechMedical Devices

Developing a gene therapy for advanced forms of basal cell carcinoma skin cancer.

Sweetch provides a patient-engagement platform that delivers personalized recommendations to help people with chronic conditions adhere to their treatment programs, covering medication adherence, physical activity, nutrition, sleep, and remote patient monitoring.

AI & Machine LearningDigital HealthHealthtech

Co-investorsEntrée CapitalLionBirdPontifax Venture CapitalTal VenturesOurCrowd

Clinical-stage neuroscience company developing ketamine-inspired compounds for depression without hallucinogenic effects.

Syndeio Biosciences is a synapse-focused biotech developing precision neurotherapeutics for neuropsychiatric, mental health, and cognitive disorders such as depression and Alzheimer's.

AI & Machine LearningBiotechDigital Health

Co-investorsEvolution VC PartnersCatalio Capital ManagementPalo Santo

Venture fund investing seed to pre-IPO in companies from the University of Melbourne ecosystem, focused on life and physical sciences.

Verge Labs builds AI models trained on multimodal human patient data to predict drug targets and patient populations for clinical development, primarily in neuroscience and central nervous system (CNS) disease.

AI & Machine LearningBiotechDeep TechDigital HealthHealthtechSan Francisco, US

Alice Zhang(Founder/CEO)inJason Chen(Cofounder)Emily Ripka(Head of Product & Engineering)

Co-investorsBOLD LongevityDraper AssociatesFitz Gate VenturesGreat Oaks Venture CapitalKarlin VenturesLifeforce Capital+5 more

Manufacturer of 5HT2A small molecules for mental health disorders using a computational approach.